Written by the AllMyPeptides Research Team
What Is SLU-PP-332?
SLU-PP-332 is a synthetic small-molecule agonist of the estrogen-related receptors (ERRα/β/γ) — not a peptide. It emerged from recent academic research and has been described as an experimental 'exercise mimetic'.
Research use only. This material is supplied for in-vitro laboratory research. It is not a medicine and is not for human or veterinary consumption, administration, or therapeutic use.
How SLU-PP-332 Is Studied to Work
In research SLU-PP-332 activates ERR signalling, a pathway involved in mitochondrial biogenesis and oxidative metabolism. In rodent studies it has been examined for effects on endurance and metabolic markers, prompting interest in exercise-physiology research.
Evidence & Regulatory Status
SLU-PP-332 is a very early-stage research compound: published data is preliminary and largely animal-based, and its safety profile is not established. It is not an approved medicine in the UK and is supplied for laboratory research only.
Research Handling & Quality
SLU-PP-332 is supplied as a research material; refer to the batch-matched Certificate of Analysis (COA) and appropriate laboratory protocols. View SLU-PP-332 product details and COA.
Frequently Asked Questions
Is SLU-PP-332 a peptide?+
Is SLU-PP-332 approved for human use?+
What does 'exercise mimetic' mean here?+
Related Guides
Products discussed in this guide are for research and laboratory use only. AllMyPeptides does not condone or support misuse of any research materials. Not for human or animal consumption.